Carbon-ion radiotherapy for non-small cell lung cancer with interstitial lung disease: a retrospective analysis

[1]  Vasilis Aidinis,et al.  Lung cancer in patients with idiopathic pulmonary fibrosis. , 2017, Pulmonary pharmacology & therapeutics.

[2]  H. Tsujii,et al.  A Dose Escalation Clinical Trial of Single‐Fraction Carbon Ion Radiotherapy for Peripheral Stage I Non–Small Cell Lung Cancer , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[3]  R. Onimaru,et al.  Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403. , 2015, International journal of radiation oncology, biology, physics.

[4]  M. Tsuboi,et al.  Pulmonary Resection for Lung Cancer in Patients With Idiopathic Interstitial Pneumonia. , 2015, The Annals of thoracic surgery.

[5]  T. Fujisawa,et al.  A prospective nonrandomized phase I/II study of carbon ion radiotherapy in a favorable subset of locally advanced non–small cell lung cancer (NSCLC) , 2015, Cancer.

[6]  K. Togashi,et al.  Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival after Stereotactic Body Radiation Therapy for Lung Cancer , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[7]  Kenji Suzuki,et al.  Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. , 2014, The Journal of thoracic and cardiovascular surgery.

[8]  Y. Korogi,et al.  Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: the potential risk of extensive radiation pneumonitis. , 2013, Lung cancer.

[9]  C. Stevens,et al.  Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung. , 2012, International journal of radiation oncology, biology, physics.

[10]  Mitsuhiro Nakamura,et al.  Dose--volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer. , 2012, International journal of radiation oncology, biology, physics.

[11]  Kenji Suzuki,et al.  The importance of intraoperative fluid balance for the prevention of postoperative acute exacerbation of idiopathic pulmonary fibrosis after pulmonary resection for primary lung cancer. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[12]  H. Collard,et al.  Clinical course and prediction of survival in idiopathic pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.

[13]  K. Ohtomo,et al.  Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy , 2010, Radiation oncology.

[14]  Andrea Bezjak,et al.  Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.

[15]  G. Raghu,et al.  Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology , 2010, European Respiratory Journal.

[16]  R. Barriger,et al.  A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy. , 2009, International journal of radiation oncology, biology, physics.

[17]  H. Shirato,et al.  Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group. , 2009, International journal of radiation oncology, biology, physics.

[18]  K. Chida,et al.  Cumulative incidence of and predictive factors for lung cancer in IPF , 2009, Respirology.

[19]  Jan-Jakob Sonke,et al.  Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  H. Tsujii,et al.  Carbon ion radiotherapy for elderly patients 80 years and older with stage I non-small cell lung cancer. , 2009, Lung cancer.

[21]  Susumu Kandatsu,et al.  Carbon Ion Radiotherapy for Stage I Non-small Cell Lung Cancer Using a Regimen of Four Fractions during 1 Week , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[22]  Ping Li,et al.  Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer. , 2006, International journal of radiation oncology, biology, physics.

[23]  Y. Onodera,et al.  Mediastinal Lymph Node Staging by FDG-PET in Patients with Non-Small Cell Lung Cancer: Analysis of False-Positive FDG-PET Findings , 2003, Respiration.

[24]  Koichiro Tatsumi,et al.  Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: analyses of short-term and long-term outcomes. , 2003, The Journal of thoracic and cardiovascular surgery.

[25]  Demosthenes Bouros,et al.  Association of malignancy with diseases causing interstitial pulmonary changes. , 2002, Chest.

[26]  P. Valk,et al.  Factors associated with false-positive staging of lung cancer by positron emission tomography. , 2000, The Annals of thoracic surgery.

[27]  S Minohara,et al.  Respiratory gated irradiation system for heavy-ion radiotherapy. , 2000, International journal of radiation oncology, biology, physics.

[28]  M. Hara,et al.  Iung cancer associated with usual interstitial pneumonia , 1995, Pathology international.

[29]  V. Poletti,et al.  The impact of lung cancer on survival of idiopathic pulmonary fibrosis. , 2015, Chest.

[30]  Y. Sugiyama,et al.  Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases. , 2015, The Journal of thoracic and cardiovascular surgery.

[31]  L. Voltolini,et al.  Impact of interstitial lung disease on short-term and long-term survival of patients undergoing surgery for non-small-cell lung cancer: analysis of risk factors. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[32]  Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. , 2004, Thorax.

[33]  D. Forman,et al.  Delays in managing lung cancer. , 2004, Thorax.

[34]  T Kanai,et al.  Irradiation of mixed beam and design of spread-out Bragg peak for heavy-ion radiotherapy. , 1997, Radiation research.